Novartis investor relations material
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. It operates through three segments: Pharmaceuticals, Alcon, and Sandoz. The company offers patented prescription drugs for cancers; cardiovascular and gastrointestinal diseases; central nervous system disorders; inflammatory ailments; and organ transplantation. The company also provides patented over-the-counter medications to treat coughs and colds; pain management; skin care; eye care; oral care; digestive health products; oral nutritionals, such as infant formulas and nutritional beverages for the elderly population based on science-based formulations using specialized processing technologies; topical antifungal treatment creams that treat athlete's foot, jock itch, ringworm, and other fungal infections of the skin, scalp or nails; smoking cessation aids under the Nicorette name in Europe and Australia/New Zealand.